Product Recalls in New Mexico

Product recalls affecting New Mexico — including food, drugs, consumer products, medical devices, and vehicles distributed to New Mexico. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,585 recalls have been distributed to New Mexico in the last 12 months.

48,595 total recalls
2,585 in last 12 months

Showing 45814600 of 13,432 recalls

DrugApril 24, 2020· Dr. Reddy's Laboratories, Inc.

Recalled Item: Esomeprazole Magnesium Delayed Release Capsules USP Recalled by Dr. Reddy's...

The Issue: Discoloration: product contains brown pellets

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 23, 2020· QuVa Pharma, Inc.

Recalled Item: R.E.C.K. (Ropivacaine Recalled by QuVa Pharma, Inc. Due to Presence of...

The Issue: Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 21, 2020· Sandoz, Inc

Recalled Item: Infuvite PEDiatric Pharmacy Recalled by Sandoz, Inc Due to Defective...

The Issue: Defective Container: Sub-optimal crimping in vial of Pediatric Infuvite...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2020· Fresenius Kabi USA, LLC

Recalled Item: Ketorolac Tromethamine Injection Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Presence of Particulate Matter - found in reserve sample vials at the firm.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: ChapStick Total Hydration Moisture + Tint + SPF15 Pretty in Recalled by...

The Issue: Labeling: Not elsewhere classified: Observed separation in the secondary...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry Recalled by...

The Issue: Labeling: Not elsewhere classified: Observed separation in the secondary...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: ChapStick Total Hydration Moisture + Tint + SPF15 Peachy Keen Recalled by...

The Issue: Labeling: Not elsewhere classified: Observed separation in the secondary...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2020· Fresenius Kabi USA, LLC

Recalled Item: Ketorolac Tromethamine Injection Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Presence of Particulate Matter - found in reserve sample vials at the firm.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to Product...

The Issue: Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 18, 2020· B. Braun Medical Inc

Recalled Item: Ceftazidime for Injection USP and Dextrose for Injection USP Recalled by B....

The Issue: Failed Stability Specifications: Out-of-Specification (OOS) results for High...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 15, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Cefixime for Oral Suspension USP Recalled by Lupin Pharmaceuticals Inc. Due...

The Issue: Subpotent Drug: low out of specification (OOS) test result observed in long...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 15, 2020· Summitt Labs

Recalled Item: KORE ORGANIC CBD Oil Watermelon 15mg* Recalled by Summitt Labs Due to...

The Issue: Chemical Contamination; product contains elevated levels of lead

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 15, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: Nizatidine Oral Solution Recalled by Amneal Pharmaceuticals of New York, LLC...

The Issue: CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 14, 2020· B & B Pharmaceuticals, Inc.

Recalled Item: Estradiol Recalled by B & B Pharmaceuticals, Inc. Due to Foreign Object...

The Issue: cGMP deviations: Presence of foreign material (Teflon)introduced at the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 14, 2020· MasterPharm LLC

Recalled Item: Finasteride Plus 1.25 mg Capsule Recalled by MasterPharm LLC Due to Cross...

The Issue: Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 3, 2020· Golden State Medical Supply Inc.

Recalled Item: Losartan Potassium Tablets Recalled by Golden State Medical Supply Inc. Due...

The Issue: CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 1, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: Presence of Foreign Tablet/ Capsule: Product complaint received indicating...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 31, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 31, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 31, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund